News & Press Releases

Select category
Filter by

Press contact: 

Burson-Marsteller

Tel: +39 02 721431.1

Antonella Violante: antonella.violante@bm.com

Alessia Quaglio: alessia.quaglio@bm.com

 

25/09/2013 Stevanato Group announces the entrance of Fabrizio Bonanni in the Board of Directors

Stevanato Group announces that Dr. Fabrizio Bonanni joined the Company as member of the Board of Directors. Dr. Bonanni boasts a large experience in the biopharmaceutical field, thanks to his previous involvement in two large American multinational companies.

02/07/2013 Stevanato Group acquires InnoScan

Stevanato Group strengthens its market position by acquiring the majority stake of InnoScan, a Danish manufacturer of state of the art high-speed inspection machines for the pharmaceutical industry.

21/03/2013 Ompi doubled the Mexican plant

Ompi doubled the size of its manufacturing plant in Mexico, Cienega de Flores in Monterrey, in the state of Nuovo Leon. The Mexican plant, opened in 2008 to serve the needs of the American market, has doubled in size thanks to an investment of around €22 million, now measuring 12,000 square metres (indoor).

19/11/2012 Ompi lays foundations in China

19 November 2012 has seen the start of work for a new production plant in Zhangjiagang, China for the pharmaceutical packaging leader Stevanato Group, based in Piombino Dese, Padua (Italy).

26/10/2012 The 2013-16 Industrial Plan has been approved: Stevanato Group aims to consolidate its international leadership

Stevanato Group SpA aims to double its sales in five years and consolidate its international leadership position in the manufacture of glass primary pharmaceutical packaging for injectable substances, a global market of which is growing at 4%.

14/06/2012 Stevanato Group sponsors the exhibition "Vetro Murrino, da Altino a Murano"

An exhibition called "Vetro Murrino, da Altino a Murano", sponsored by Stevanato Group, will take place starting from 17th June 2012 until 6th January 2013.

29/11/2011 Doubling the size of the plant in Mexico

"Organic growth", said Company President Cav. Sergio Stevanato, "is the basis of every solid industrial company. That's why, in keeping with our business plan, we have decided to begin doubling the plant in Mexico. The investment plan will initially open with the amount of 4.5 million Euros, which is expected to double early in 2012, and will reach 30 million by the time the plant has been completed."

29/10/2009 The pharmaceutical world in Venice for Stevanato Group

Venice, October 28, 2009 - Today the Island of San Giorgio in Venice hosted 300 representatives of the leading players in the worldwide pharmaceutical industry for a meeting on quality, product and service innovation, and internationalization.